Save information for later
Sign Up

Learn About Hygroma Cervical

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Hygroma Cervical Local Doctors?
Elite in Hygroma Cervical
Elite in Hygroma Cervical
No.84, Gongzhuan Rd, 
Taishan, TPQ, TW 

Chih-ping Chen practices in Taishan, Taiwan. Chen and is rated as an Elite expert by MediFind in the treatment of Hygroma Cervical. Their top areas of expertise are Trisomy 14 Mosaicism, Cystic Hygroma, Trisomy 13, and Mosaic Trisomy 7.

Advanced in Hygroma Cervical
Neurosurgery | Interventional Radiology
Advanced in Hygroma Cervical
Neurosurgery | Interventional Radiology

Yale University

20 York St, 
New Haven, CT 
Languages Spoken:
English
Offers Telehealth

Charles Matouk is a Neurosurgery specialist and an Interventional Radiologist in New Haven, Connecticut. Dr. Matouk and is rated as an Advanced provider by MediFind in the treatment of Hygroma Cervical. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Hydrocephalus, Thrombectomy, and Stent Placement.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Hygroma Cervical
Advanced in Hygroma Cervical

The Oregon Clinic, PC

9155 Sw Barnes Rd, Suite 440, 
Portland, OR 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Vivek Deshmukh is a Neurosurgery provider in Portland, Oregon. Dr. Deshmukh and is rated as an Advanced provider by MediFind in the treatment of Hygroma Cervical. His top areas of expertise are Brain Aneurysm, Spinal Tumor, Stroke, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery. Dr. Deshmukh is currently accepting new patients.

What are the latest Hygroma Cervical Clinical Trials?
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)

Summary: Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effectiveness of (i) 48 weeks of alpelisib therapy for participants with slow-flow vascular malformations and a gene mutation...

Match to trials
Find the right clinical trials for you in under a minute
Get started